Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - quetiapine fumarate -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - escitalopram oxalate, quantity: 25.552 mg (equivalent: escitalopram, qty 20 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; macrogol 400; hypromellose; microcrystalline cellulose; purified talc; titanium dioxide; colloidal anhydrous silica - treatment of major depression, social anxiety disorder (social phobia), generalised anxiety disorder and obsessive-compulsive disorder.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - escitalopram oxalate, quantity: 12.776 mg (equivalent: escitalopram, qty 10 mg) - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; croscarmellose sodium; titanium dioxide; macrogol 400; colloidal anhydrous silica; microcrystalline cellulose; purified talc - treatment of major depression, social anxiety disorder (social phobia), generalised anxiety disorder and obsessive-compulsive disorder.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).